Citations(0)

Content

How to Cite This Article

Download Download [ PDF ]

Email Send to a friend

Page Views Page Views(671)

Facebook ShareFacebook Share

Twitter ShareTwitter Share

Year : 2019 Month : August Volume : 8 Issue : 34 Page : 2658-2661

An Investigation into the Relationship between N-Terminal Pro B-Type Natriuretic Peptide (NT-proBNP) and Fragmented QRS in Patients with Chronic Heart Failure.

Javad Ramezani1, Zahra Sharifi2, Shirin Sadat Ghiasi3, Majid Jalalyazdi4

1Assistant Professor, Cardiologist, Department of Cardiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. 2Resident, MD, Department of Cardiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. 3Medical Student, MD, Researcher, Department of Cardiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. 4Assistant Professor, Cardiologist, Department of Cardiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.


CORRESPONDING AUTHOR

Majid Jalalyazdi
Email : drmajidjalayazdi@yahoo.com

ABSTRACT

Corresponding Author:
Majid Jalalyazdi
Department of Cardiology,
School of Medicine,
Mashhad University of Medical Sciences,
Mashhad, Iran.
E-mail: drmajidjalayazdi@yahoo.com

ABSTRACT

BACKGROUND

Heart failure is a clinical syndrome characterized by a constellation of symptoms and signs often caused by a structural and/or functional cardiac abnormality resulting in reduced cardiac output and/or elevated intracardiac pressures. Fragmented QRS (fQRS) complex is associated with fibrosis or myocardial scar in patients with structural heart disease. Patients, especially cardiologists, are particularly concerned about heart failure in people suffering from dyspnoea. The prevalence of this disease is rising in industrial countries. The relationship between NT-proBNP and fragmented QRS in patients with chronic heart failure was investigated in this study.

METHODS

The population included 42 patients suffering from chronic heart failure. fQRS was described as ≥1 additional deflection, including the peak of the R-wave or the nadir of S-wave, in at least two continuous leads. According to the absence of fQRS [fQRS (-)] or presence of fQRS (n= 22 and n= 20, respectively), the patients were assigned to two groups. The statistical package for social sciences (SPSS, version 22) was used to analyse the data. Furthermore, the normality of the data was investigated by the Shapiro-Wilk test. The chi-square test and independent t-test were used to compare the variables.

RESULTS

42 patients (18 women and 24 men) aged 54.78±6.43 years participated in this study. Given the fQRS at hospitalization, the patients were assigned to fQRS (–) (n= 20) and fQRS (+) (n= 22) groups. The results showed that NT-proBNP level was significantly lower in fQRS (-) group (p < 0.001), compared to fQRS (+) group. There was a significant difference between the two groups in terms of NYHA, blood pressure, hypertension, diabetes and hyperlipidaemia. The groups were compared in terms of demographic characteristics, angiography including hyperlipidaemia, and history of cardiovascular diseases. The fQRS (+) group exhibited a higher proportion of hyperlipidaemia (63.40%), troponin I (34.33 ± 21.87) and NT-proBNP (242.34 ± 42.65) than the fQRS (-) group.

CONCLUSIONS

The results showed a significant relationship between fQRS and the higher levels of NT-proBNP. The fQRS was associated with increased NT-proBNP and pronounced LV end-diastolic pressure in heart failure patients.

KEY WORDS

Heart Failure, NT-proBNP, Fragmented QRS

BACKGROUND

Heart failure presents a multifactorial, systemic disease, in which, after a cardiac injury, structural, neurohumoral, cellular, and molecular mechanisms are activated and act as a network to maintain physiological functioning.(1) Also, this is a clinical syndrome characterized by a constellation of symptoms (Dyspnoea, orthopnoea, lower limb swelling) and signs (Elevated jugular venous pressure, pulmonary congestion) often caused by a structural and/or functional cardiac abnormality resulting in reduced cardiac output and/or elevated intracardiac pressures. (2) The incidence and prevalence of heart failure increase strikingly with age and make heart failure the most common reason for hospitalization among older adults. Although outcomes for older adults with heart failure have improved over time, mortality, hospitalization, and rehospitalization rates remain high.(3) Patients, especially cardiologists, are particularly concerned about heart failure in people suffering from dyspnoea. The prevalence of this disease is rising in the industrial countries. It reportedly accounts for 600.000 cases annually.(4) Heart failure can also be regarded as an economic issue which imposes a great deal of costs on the medical systems and leads to disability and decreased ability to work.(5) Given the economic costs imposed on society due to the prevalence of heart failure as well as the fact that this disease affects the quality of life of the patient, rapid diagnosis and immediate treatment of patients with heart failure is required to prevent or delay the progression of the disease.(6) Although echocardiography is the gold standard for diagnostic purposes, it is usually not available in many primary care settings, it is expensive and may not be accurate in many acute conditions.(7) Furthermore, echocardiography is time-consuming and requires the individual's skill and expertise to be performed and interpreted. If a patient with dyspnoea suffers from heart failure and it remains undiagnosed, the disease may progress and kill the patient finally.(8)

Fragmented QRS (fQRS) complex is associated with fibrosis or myocardial scar in patients with structural heart disease is recorded on the surface of electrocardiograms (ECGs).(9) According to the previous studies, fQRS complex was a good predictor of adverse cardiovascular conditions such as cardiac death. Meanwhile, some other studies found that myocardial scar or conduction disturbance may cause significant abnormality with the fQRS complex. For example, patients with left ventricular hypertrophy who also suffer from a notch in the fQRS complex may show a defects in the intraventricular conduction.(10) The injured tissues around an infarct scar may lead to RSR' pattern in the QRS.(11) Despite the fact the past research has focused on the relationship between cardiac complications and fQRS, there is still little information about the prognostic and diagnostic values of the QRS complex abnormalities. According to some studies, fQRS was associated with arrhythmic events and mortality in patients with structural heart disease (SHD). According to some studies, patients suffering from coronary artery disease who had fQRS showed myocardial conduction block. This may be attributed to the myocardial scar. To detect this complication, myocardial single photon emission tomography was used. Using fQRS in patients with prior myocardial
infarction could contribute to the evaluation of CAD. Further showed that fQRS can be used as a potential indicator to diagnose or predict the ischemic cardiomyopathy and some electrical diseases.(12) We aimed to examine the relationship between fragmented QRS and NT-proBNP in patients with chronic heart failure.

 

METHODS

This diagnostic clinical trial study was conducted on patients referring to the clinic from March to June 2017. The patients provided informed consent to work on the plan. According to the criteria of the European Society of Heart Association, the inclusion criteria were the approval of acute myocardial infarction (AMI) and patients whose main complaint was dyspnoea. Patients with heart failure who received guideline mediated treatment were included in this study. According to the inclusion and exclusion criteria, 42 patients participated in the study. Several morphologies of the QRS (< 120 ms) are included in the fQRS, including notching in the nadir of the S wave and additional R wave (R’). Given the fQRS [fQRS (-)] or fQRS [fQRS (+)] (n= 22 and n= 20, respectively), the patients were assigned to two groups. All the patients were asked to give their blood sample within 24 hours. Accordingly, Creatinine, NT-proBNP troponin I and urea were measured on a daily basis.

 

Statistical Analysis

The statistical package for social sciences (SPSS, version 22) was used to analyse the data. Furthermore, the normality of the data was investigated by the Shapiro-Wilk test. The chi-square test and independent t-test were used to compare the variables.

RESULTS

42 patients (18 women and 24 men) aged 54.78±6.43 years participated in this study. Given the fQRS at hospitalization, the patients were assigned to fQRS (–) (n= 20) and fQRS (+) (n= 22) groups. Table 1 shows the echocardiographic and baseline demographic characteristics of the patients. There was a significant difference between the two groups in terms of NYHA, blood pressure, hypertension, diabetes and hyperlipidaemia. Table 2 shows the laboratory characteristics of the fQRS groups.

 

 

fQRS (+) Group

(n= 22)

fQRS (–) Group

(n= 20)

p Value

Age, years

55.45±6.57

53.56±7.45

0.343

Men, n (%)

13(63.40)

11(50.00)

0.654

Current smoker, n (%)

12(54.54)

11(55.00)

0.347

Hypertension, n (%)

11(50.00)

9(45.00)

0.784

Hyperlipidemia, n (%)

13(63.40)

12(60.00)

0.459

Diabetes, n (%)

8(36.36)

8(40.00)

0.454

SBP, mmHg

117±32

117±21

0.132

DBP, mmHg

70±13

70±14

0.787

NYHA class, n (%)

 

 

 

II

10(45.56)

9(45.00)

0.346

III

12(54.54)

11(55.00)

0.436

Ejection Fraction

39±6

40±5

0.236

Table 1. Baseline Demographic and Echocardiographic    Characteristics of fQRS (+) and fQRS (-) Groups

 

 

fQRS (+) Group

(n= 22)

fQRS (–) Group

(n= 20)

p Value

Hemoglobin, g/dL

13.2±2.3

13.5± 1.99

0.143

Glucose, mg/dL

90±11

92±8

0.425

Creatinine, mg/dL

1.08±9.8

1.10± 0.14

0.656

Troponin I, μg/L

34.33±21.87

22.56±12.7

0.002

Total cholesterol, mg/L

210.43±21.54

215.67±34.21

0.433

LDL-cholesterol, mg/L

100.56±10.87

104.76±10.74

0.675

HDL-cholesterol, mg/L

44.54±6.75

42.54±6.36

0.187

Triglyceride, mg/L

160.65±45.21

157.87±33.17

0.823

NT-proBNP, pg/mL

242.34 ±42.65

117.76±65.76

0.001

Table 2. Baseline Laboratory Characteristics of fQRS (+)                                     and fQRS (-) Groups

 

There was no significant difference between the two groups in terms of NYHA, hypertension, hypertension, diabetes. However, according to Table 2, there is a significant difference between the two fQRS (+) and fQRS (-) groups in terms of troponin I and NT-proBNP at level 95% (p value= 0.002 and p value= 0.001, respectively). However, no significant difference was found between the two groups in terms of other laboratory characteristics. The groups were compared in terms of demographic characteristics, angiography including hyperlipidaemia, and history of cardiovascular diseases. The fQRS (+) group exhibited a higher proportion of hyperlipidaemia (63.40%), troponin I (34.33 ± 21.87) and NT-proBNP (242.34 ± 42.65) than the fQRS (-) group.

 

DISCUSSION

Heart failure (HF) is the leading cause of morbidity and mortality worldwide and negatively impacts quality of life, healthcare costs, and longevity (13). In this research, we investigated the relationship between fragmented QRS and NT-proBNP in patients with chronic heart failure. According to the findings, NT-proBNP level was significantly lower in fQRS (-) group (p < 0.001), compared to fQRS (+) group. The natriuretic peptides are not highly recommended for diagnosing heart failure. However, they can estimate the prognosis and severity of the heart failure. NT-proBNP and -type natriuretic peptide (BNP) are two of the most widely used natriuretic peptides, which are secreted in response to stretch.(14) These biomarkers can help detect natriuretic peptides in blood.(14) As NYHA functional class worsens in terms of function, the amount of natriuretic peptides significantly. Meanwhile, the result showed that the amount of natriuretic peptide was higher in HFrEF than HFpEF. This difference can help increase the concentrations of natriuretic peptides. According to the results, patients with acute HF had higher BNP and NT-proBNP, compared to stable patients with CHF. However, further research is required to confirm this finding. It is necessary to specify the amount of natriuretic peptide in stable patients in order to provide an insight into the changes in HF symptoms.(15,16) Zhang et al. (2017) examined the prognostic value of the complex QRS (fQRS) for microvascular reperfusion and changes in left ventricular function in patients with myocardial infarction. Zhang et al. (2017) examined 216 patients. The patients were divided into two groups (of 126 and 90) based on the presence or absence of fQRS. In both groups, troponin levels, NT-proBNP and creatine kinase were studied. Zhang stated that in the analysis of logistic regression, LV-FV (LVEF) NT-proBNP,
Troponin I and microvascular reperfusion were associated with fQRS. Moreover, Zhang stated that the presence of fQRS was not only significantly associated with the myocardial microvascular reperfusion and left ventricular function, but also with the prognosis of STEMI. However, our study showed that fQRS was directly associated with NT-proBNP.(16)

Barman and et al. (2019) aimed to investigate the relationship between the presence of fragmented QRS (fQRS) on electrocardiogram (ECG) and plasma galectin-3 levels in patients with heart failure (HF) and severely decreased left ventricular ejection fraction. They show fQRS and serum galectin-3 levels are associated with myocardial fibrosis and are associated with poor prognosis in heart failure. In their study, a positive correlation was found between serum galectin-3 levels and fQRS on ECG.(17) Zhao et al (2018) showed that there was an association between fragmented QRS and NT-proBNP among patients with myocardial infarction. In this study, 216 patients were studied. Zhao stated that the presence of fQRS was significantly associated with NT-proBNP and left ventricular ejection fraction, which can predict left ventricular function in patients with STEMI. fQRS is a prognostic marker of ventricular cytology dysfunction. This was in good agreement with the results obtained in our study.(18) According to Mueller et al., the highest diagnostic accuracy in NT-ProBNP, pg/ cc 825 was reported with 82% sensitivity and 81% specificity, while the sensitivity and specificity in our study were 95% and 89%, respectively. This was slightly different compared to Mueller. This difference can be attributed to the age range of the subjects under study, the frequency of sex and the systolic intensity of left ventricular dysfunction.(4)

The fQRS is a readily available, inexpensive and non-invasive ECG parameter. Cardiac remodelling can produce scar or fibrotic tissue, causing congestive heart failure, hemodynamically significant arrhythmias and cardiovascular death. The presence of fQRS can predict myocardial perfusion and left ventricular function. In addition, the results showed that narrowed fQRS could increase the incidence of major adverse cardiovascular complications, including hemodynamically significant ventricular arrhythmic complications, hypertrophic obstructive cardiomyopathy, acute coronary syndromes, decompensated systolic heart failure and non-ischemic cardiomyopathy.(19,20) FQRS on ECG can serve as be used to detect myocardial fibrosis. 9.2% of healthy middle-aged Finnish subjects were reportedly received fQRS. However, higher prevalence of fQRS were observed in several diseases, including cardiac sarcoidosis (75%), ST elevation myocardial infarction (21.9%) and chronic kidney disease (60%).(21)

CONCLUSIONS

FQRS is a widely used method for HF patients. The results showed a significant relationship between fQRS and the higher levels of NT-proBNP. The fQRS was associated with increased NT-proBNP and pronounced LV end-diastolic pressure in heart failure patients.

 

 

Videos :

watch?v